HomeAbout usProductsInvestor centreMedia centrePartneringCareers

Regulatory announcements

Information on this page is updated via a live feed (20 minute delay) from the London Stock Exchange's Regulatory News Service (RNS).

To retrieve the full story, please click on the headline. This page contains the most recent announcements. To view earlier items, please search the Regulatory News Archive.



Date Title
02/06/2009 REG-Antisoma plc: Total voting rights
31/05/2009 REG-Antisoma plc: Antisoma's AS1409 shows anti-cancer activity in phase I trial
29/05/2009 REG-Antisoma plc: Antisoma to advance AS1411 in AML based on positive phase II data presented at ASCO
21/05/2009 REG-Antisoma plc: Phase II trial of ASA404 published in Lung Cancer
12/05/2009 REG-Antisoma plc: Antisoma sells oral fludarabine to sanofi-aventis U.S. for USD 65 million
07/05/2009 REG-Antisoma plc: Antisoma Interim Management Statement
01/05/2009 REG-Antisoma plc: Total voting rights
20/04/2009 REG-Antisoma plc: Data on three Antisoma drugs presented at AACR meeting
14/04/2009 REG-Antisoma plc: Block listing Interim Review
08/04/2009 REG-Antisoma plc: Payment of Directors' Fees in Shares
Page: <<  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46    >>
Delivered by Investis and link to website (opens in a new window)